Radiopharmaceutical Market - Global Industry Research Analysis
Radiopharmaceutical Market By Key Players (NTP Radioisotopes SOC Ltd, Eckert & Ziegler Group, Advanced Accelerator Applications SA, Cardinal Health Inc); Global Report by Size, Share, Industry Analysis, Growth Trends, Regional Outlook, and Forecast 2024-2032
Published: Jan-2021 | Format: PDF | Maia Research | Number of pages: 113 | Code: MRS - 814336
The report on the Global Radiopharmaceutical Market has published by the Market Research Store. The report provides the client the latest trending insights about the Radiopharmaceutical market. You will find in the report include market value and growth rate, size, production consumption and gross margin, pricings, and other influential factors. Along with these you will get detailed information about all the distributors, suppliers and retailers of the Radiopharmaceutical market in the report. The competitive scenario of all the industry players are mentioned in-detail in the report. Due to the pandemic the market players have strategically changed their business plans.
Some of the key industry players that are operating in the Radiopharmaceutical market are:
Clarity Pharmaceuticals
Advanced Accelerator Applications SA
Eckert & Ziegler Group
Eczacibasi-Monrol
Cardinal Health Inc
Ion Beam Applications SA (IBA)
Lantheus Medical Imaging Inc
GE Healthcare
Life Molecular Imaging GmbH
Bayer AG
Alpha Tau Medical Ltd.
Bracco Diagnostics Inc
Orano Med
Curium Pharma
Siemens Healthineers
Telix Pharmaceuticals Limited
NTP Radioisotopes SOC Ltd
Blue Earth Diagnostics Limited
Through the month of the analysis, research analysts predicted that the Radiopharmaceutical market reached XX million dollars in 2019 and the market demand will reach XX million dollars by 2026. During the forecast period 2020 to 2026 the expected CAGR is XX%. The increasing investments in the research and development activities and the rising technological advancements in the Radiopharmaceutical market, increasing the market growth.
Due to the increase of pandemic world-wide several market issues has generated around the world. Such as, economic crisis in various regions along with loss of employment.
The questions that are answered in the report:
What are the challenges for the Radiopharmaceutical market created by the outbreak of the global pandemic?
What are the drivers that are shaping the Radiopharmaceutical market?
What are the top opportunities that are currently ruling the market?
What are the segments of the Radiopharmaceutical market that are given in the report?
What are the developing regions in the Radiopharmaceutical market?
Overall industries are struggling on the global platform to revive the markets. It has been observed that through the pandemic almost every market domain has been impacted.
Market Segmentation
The Radiopharmaceutical market regional presence is showcased in five major regions Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. In the report, the country-level analysis is also provided.
The Radiopharmaceutical market is segmented into Product Types:
Technetium-99
Gallium-67
Iodine-123
18F
Rubidium-82
Yttrium-90
Lutetium-177
The Radiopharmaceutical market is segmented into By End User/Application:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
The major points that are covered in the report:
Overview: In this section, the global Radiopharmaceutical Market definition is given, with an overview of the report in order to provide a board outlook about the nature and contents of the research study.
Strategies Analysis of Industry Players: This Strategic Analysis will help to gain competitive advantage over their competitors to the market players.
Essential Market Trends: Depth analysis of the market’s latest and future trends is provided in this section.
Market Forecasts: In this segment, accurate and validated values of the total market size in terms of value and volume have provided by the research analyst. Also the report include production, consumption, sales, and other forecasts for the global Radiopharmaceutical Market.
Regional Analysis: In the global Radiopharmaceutical market report major five regions and its countries have been covered. Market players will have estimates about the untapped regional markets and other benefits with the help of this analysis.
Segment Analysis: Accurate and reliable foretell about the market share of the essential sections of the Radiopharmaceutical market is provided.
These dominant industry players use well planned strategies to occupied highest market share in this market. Some of the top players in Radiopharmaceutical business includes.
The statistical data of the dominant industry player of Radiopharmaceutical market can be acquired from the company profile segment described in the report. This segment come up with analysis of major player’s in the Radiopharmaceutical market, also their last five-year revenue, segmental, product offerings, key strategies adopted and geographical revenue produced.
The report come up with a segment of the Radiopharmaceutical market based on Type, Region, and Application, Also offer a determined view on the Radiopharmaceutical market.
The report offers a nitty-gritty estimation of the market by providing data on various viewpoints that incorporate, restraints, drivers, and opportunities threats. This data can help in making suitable decisions for stakeholders before investing.
The sample report for Radiopharmaceutical market can be received after the apply from the website.
Table Of Content
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Radiopharmaceutical Market Share by Type (2020-2026)
1.5.2 Technetium-99
1.5.3 Gallium-67
1.5.4 Iodine-123
1.5.5 18F
1.5.6 Rubidium-82
1.5.7 Yttrium-90
1.5.8 Lutetium-177
1.6 Market by Application
1.6.1 Global Radiopharmaceutical Market Share by Application (2020-2026)
1.6.2 Hospitals
1.6.3 Ambulatory Surgical Centers
1.6.4 Diagnostic Centers
1.6.5 Others
1.7 Radiopharmaceutical Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Radiopharmaceutical Industry Development
2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19
3 Value Chain of Radiopharmaceutical Market
3.1 Value Chain Status
3.2 Radiopharmaceutical Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Radiopharmaceutical
3.2.3 Labor Cost of Radiopharmaceutical
3.2.3.1 Labor Cost of Radiopharmaceutical Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19
4 Players Profiles
4.1 Clarity Pharmaceuticals
4.1.1 Clarity Pharmaceuticals Basic Information
4.1.2 Radiopharmaceutical Product Profiles, Application and Specification
4.1.3 Clarity Pharmaceuticals Radiopharmaceutical Market Performance (2015-2020)
4.1.4 Clarity Pharmaceuticals Business Overview
4.2 Advanced Accelerator Applications SA
4.2.1 Advanced Accelerator Applications SA Basic Information
4.2.2 Radiopharmaceutical Product Profiles, Application and Specification
4.2.3 Advanced Accelerator Applications SA Radiopharmaceutical Market Performance (2015-2020)
4.2.4 Advanced Accelerator Applications SA Business Overview
4.3 Eckert & Ziegler Group
4.3.1 Eckert & Ziegler Group Basic Information
4.3.2 Radiopharmaceutical Product Profiles, Application and Specification
4.3.3 Eckert & Ziegler Group Radiopharmaceutical Market Performance (2015-2020)
4.3.4 Eckert & Ziegler Group Business Overview
4.4 Eczacibasi-Monrol
4.4.1 Eczacibasi-Monrol Basic Information
4.4.2 Radiopharmaceutical Product Profiles, Application and Specification
4.4.3 Eczacibasi-Monrol Radiopharmaceutical Market Performance (2015-2020)
4.4.4 Eczacibasi-Monrol Business Overview
4.5 Cardinal Health, Inc
4.5.1 Cardinal Health, Inc Basic Information
4.5.2 Radiopharmaceutical Product Profiles, Application and Specification
4.5.3 Cardinal Health, Inc Radiopharmaceutical Market Performance (2015-2020)
4.5.4 Cardinal Health, Inc Business Overview
4.6 Ion Beam Applications SA (IBA)
4.6.1 Ion Beam Applications SA (IBA) Basic Information
4.6.2 Radiopharmaceutical Product Profiles, Application and Specification
4.6.3 Ion Beam Applications SA (IBA) Radiopharmaceutical Market Performance (2015-2020)
4.6.4 Ion Beam Applications SA (IBA) Business Overview
4.7 Lantheus Medical Imaging, Inc
4.7.1 Lantheus Medical Imaging, Inc Basic Information
4.7.2 Radiopharmaceutical Product Profiles, Application and Specification
4.7.3 Lantheus Medical Imaging, Inc Radiopharmaceutical Market Performance (2015-2020)
4.7.4 Lantheus Medical Imaging, Inc Business Overview
4.8 GE Healthcare
4.8.1 GE Healthcare Basic Information
4.8.2 Radiopharmaceutical Product Profiles, Application and Specification
4.8.3 GE Healthcare Radiopharmaceutical Market Performance (2015-2020)
4.8.4 GE Healthcare Business Overview
4.9 Life Molecular Imaging GmbH
4.9.1 Life Molecular Imaging GmbH Basic Information
4.9.2 Radiopharmaceutical Product Profiles, Application and Specification
4.9.3 Life Molecular Imaging GmbH Radiopharmaceutical Market Performance (2015-2020)
4.9.4 Life Molecular Imaging GmbH Business Overview
4.10 Bayer AG
4.10.1 Bayer AG Basic Information
4.10.2 Radiopharmaceutical Product Profiles, Application and Specification
4.10.3 Bayer AG Radiopharmaceutical Market Performance (2015-2020)
4.10.4 Bayer AG Business Overview
4.11 Alpha Tau Medical Ltd.
4.11.1 Alpha Tau Medical Ltd. Basic Information
4.11.2 Radiopharmaceutical Product Profiles, Application and Specification
4.11.3 Alpha Tau Medical Ltd. Radiopharmaceutical Market Performance (2015-2020)
4.11.4 Alpha Tau Medical Ltd. Business Overview
4.12 Bracco Diagnostics, Inc
4.12.1 Bracco Diagnostics, Inc Basic Information
4.12.2 Radiopharmaceutical Product Profiles, Application and Specification
4.12.3 Bracco Diagnostics, Inc Radiopharmaceutical Market Performance (2015-2020)
4.12.4 Bracco Diagnostics, Inc Business Overview
4.13 Orano Med
4.13.1 Orano Med Basic Information
4.13.2 Radiopharmaceutical Product Profiles, Application and Specification
4.13.3 Orano Med Radiopharmaceutical Market Performance (2015-2020)
4.13.4 Orano Med Business Overview
4.14 Curium Pharma
4.14.1 Curium Pharma Basic Information
4.14.2 Radiopharmaceutical Product Profiles, Application and Specification
4.14.3 Curium Pharma Radiopharmaceutical Market Performance (2015-2020)
4.14.4 Curium Pharma Business Overview
4.15 Siemens Healthineers
4.15.1 Siemens Healthineers Basic Information
4.15.2 Radiopharmaceutical Product Profiles, Application and Specification
4.15.3 Siemens Healthineers Radiopharmaceutical Market Performance (2015-2020)
4.15.4 Siemens Healthineers Business Overview
4.16 Telix Pharmaceuticals Limited
4.16.1 Telix Pharmaceuticals Limited Basic Information
4.16.2 Radiopharmaceutical Product Profiles, Application and Specification
4.16.3 Telix Pharmaceuticals Limited Radiopharmaceutical Market Performance (2015-2020)
4.16.4 Telix Pharmaceuticals Limited Business Overview
4.17 NTP Radioisotopes SOC Ltd
4.17.1 NTP Radioisotopes SOC Ltd Basic Information
4.17.2 Radiopharmaceutical Product Profiles, Application and Specification
4.17.3 NTP Radioisotopes SOC Ltd Radiopharmaceutical Market Performance (2015-2020)
4.17.4 NTP Radioisotopes SOC Ltd Business Overview
4.18 Blue Earth Diagnostics Limited
4.18.1 Blue Earth Diagnostics Limited Basic Information
4.18.2 Radiopharmaceutical Product Profiles, Application and Specification
4.18.3 Blue Earth Diagnostics Limited Radiopharmaceutical Market Performance (2015-2020)
4.18.4 Blue Earth Diagnostics Limited Business Overview
5 Global Radiopharmaceutical Market Analysis by Regions
5.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Regions
5.1.1 Global Radiopharmaceutical Sales by Regions (2015-2020)
5.1.2 Global Radiopharmaceutical Revenue by Regions (2015-2020)
5.2 North America Radiopharmaceutical Sales and Growth Rate (2015-2020)
5.3 Europe Radiopharmaceutical Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Radiopharmaceutical Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Radiopharmaceutical Sales and Growth Rate (2015-2020)
5.6 South America Radiopharmaceutical Sales and Growth Rate (2015-2020)
6 North America Radiopharmaceutical Market Analysis by Countries
6.1 North America Radiopharmaceutical Sales, Revenue and Market Share by Countries
6.1.1 North America Radiopharmaceutical Sales by Countries (2015-2020)
6.1.2 North America Radiopharmaceutical Revenue by Countries (2015-2020)
6.1.3 North America Radiopharmaceutical Market Under COVID-19
6.2 United States Radiopharmaceutical Sales and Growth Rate (2015-2020)
6.2.1 United States Radiopharmaceutical Market Under COVID-19
6.3 Canada Radiopharmaceutical Sales and Growth Rate (2015-2020)
6.4 Mexico Radiopharmaceutical Sales and Growth Rate (2015-2020)
7 Europe Radiopharmaceutical Market Analysis by Countries
7.1 Europe Radiopharmaceutical Sales, Revenue and Market Share by Countries
7.1.1 Europe Radiopharmaceutical Sales by Countries (2015-2020)
7.1.2 Europe Radiopharmaceutical Revenue by Countries (2015-2020)
7.1.3 Europe Radiopharmaceutical Market Under COVID-19
7.2 Germany Radiopharmaceutical Sales and Growth Rate (2015-2020)
7.2.1 Germany Radiopharmaceutical Market Under COVID-19
7.3 UK Radiopharmaceutical Sales and Growth Rate (2015-2020)
7.3.1 UK Radiopharmaceutical Market Under COVID-19
7.4 France Radiopharmaceutical Sales and Growth Rate (2015-2020)
7.4.1 France Radiopharmaceutical Market Under COVID-19
7.5 Italy Radiopharmaceutical Sales and Growth Rate (2015-2020)
7.5.1 Italy Radiopharmaceutical Market Under COVID-19
7.6 Spain Radiopharmaceutical Sales and Growth Rate (2015-2020)
7.6.1 Spain Radiopharmaceutical Market Under COVID-19
7.7 Russia Radiopharmaceutical Sales and Growth Rate (2015-2020)
7.7.1 Russia Radiopharmaceutical Market Under COVID-19
8 Asia-Pacific Radiopharmaceutical Market Analysis by Countries
8.1 Asia-Pacific Radiopharmaceutical Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Radiopharmaceutical Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Radiopharmaceutical Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Radiopharmaceutical Market Under COVID-19
8.2 China Radiopharmaceutical Sales and Growth Rate (2015-2020)
8.2.1 China Radiopharmaceutical Market Under COVID-19
8.3 Japan Radiopharmaceutical Sales and Growth Rate (2015-2020)
8.3.1 Japan Radiopharmaceutical Market Under COVID-19
8.4 South Korea Radiopharmaceutical Sales and Growth Rate (2015-2020)
8.4.1 South Korea Radiopharmaceutical Market Under COVID-19
8.5 Australia Radiopharmaceutical Sales and Growth Rate (2015-2020)
8.6 India Radiopharmaceutical Sales and Growth Rate (2015-2020)
8.6.1 India Radiopharmaceutical Market Under COVID-19
8.7 Southeast Asia Radiopharmaceutical Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Radiopharmaceutical Market Under COVID-19
9 Middle East and Africa Radiopharmaceutical Market Analysis by Countries
9.1 Middle East and Africa Radiopharmaceutical Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Radiopharmaceutical Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Radiopharmaceutical Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Radiopharmaceutical Market Under COVID-19
9.2 Saudi Arabia Radiopharmaceutical Sales and Growth Rate (2015-2020)
9.3 UAE Radiopharmaceutical Sales and Growth Rate (2015-2020)
9.4 Egypt Radiopharmaceutical Sales and Growth Rate (2015-2020)
9.5 Nigeria Radiopharmaceutical Sales and Growth Rate (2015-2020)
9.6 South Africa Radiopharmaceutical Sales and Growth Rate (2015-2020)
10 South America Radiopharmaceutical Market Analysis by Countries
10.1 South America Radiopharmaceutical Sales, Revenue and Market Share by Countries
10.1.1 South America Radiopharmaceutical Sales by Countries (2015-2020)
10.1.2 South America Radiopharmaceutical Revenue by Countries (2015-2020)
10.1.3 South America Radiopharmaceutical Market Under COVID-19
10.2 Brazil Radiopharmaceutical Sales and Growth Rate (2015-2020)
10.2.1 Brazil Radiopharmaceutical Market Under COVID-19
10.3 Argentina Radiopharmaceutical Sales and Growth Rate (2015-2020)
10.4 Columbia Radiopharmaceutical Sales and Growth Rate (2015-2020)
10.5 Chile Radiopharmaceutical Sales and Growth Rate (2015-2020)
11 Global Radiopharmaceutical Market Segment by Types
11.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Radiopharmaceutical Sales and Market Share by Types (2015-2020)
11.1.2 Global Radiopharmaceutical Revenue and Market Share by Types (2015-2020)
11.2 Technetium-99 Sales and Price (2015-2020)
11.3 Gallium-67 Sales and Price (2015-2020)
11.4 Iodine-123 Sales and Price (2015-2020)
11.5 18F Sales and Price (2015-2020)
11.6 Rubidium-82 Sales and Price (2015-2020)
11.7 Yttrium-90 Sales and Price (2015-2020)
11.8 Lutetium-177 Sales and Price (2015-2020)
12 Global Radiopharmaceutical Market Segment by Applications
12.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Radiopharmaceutical Sales and Market Share by Applications (2015-2020)
12.1.2 Global Radiopharmaceutical Revenue and Market Share by Applications (2015-2020)
12.2 Hospitals Sales, Revenue and Growth Rate (2015-2020)
12.3 Ambulatory Surgical Centers Sales, Revenue and Growth Rate (2015-2020)
12.4 Diagnostic Centers Sales, Revenue and Growth Rate (2015-2020)
12.5 Others Sales, Revenue and Growth Rate (2015-2020)
13 Radiopharmaceutical Market Forecast by Regions (2020-2026)
13.1 Global Radiopharmaceutical Sales, Revenue and Growth Rate (2020-2026)
13.2 Radiopharmaceutical Market Forecast by Regions (2020-2026)
13.2.1 North America Radiopharmaceutical Market Forecast (2020-2026)
13.2.2 Europe Radiopharmaceutical Market Forecast (2020-2026)
13.2.3 Asia-Pacific Radiopharmaceutical Market Forecast (2020-2026)
13.2.4 Middle East and Africa Radiopharmaceutical Market Forecast (2020-2026)
13.2.5 South America Radiopharmaceutical Market Forecast (2020-2026)
13.3 Radiopharmaceutical Market Forecast by Types (2020-2026)
13.4 Radiopharmaceutical Market Forecast by Applications (2020-2026)
13.5 Radiopharmaceutical Market Forecast Under COVID-19
14 Appendix
14.1 Methodology
14.2 Research Data Source
Inquiry For Buying
Radiopharmaceutical
Please fill out the form. We will contact you within 24 hours:
All fields required...
Request Sample
Radiopharmaceutical
Please fill out the form. We will contact you within 24 hours:
Thank you for your interest in our research report.
We will be sending you the sample copy of the report shortly. Meanwhile, if you have any specific research requirement then please let us know. We will be glad to assist you in case you have any additional questions, so feel free to get in touch